文献速递心力衰竭与心肌病

早期活检证实的暴发性心肌炎与结局

Fulminant myocarditis proven by early biopsy and outcomes.
PubMed 文献 · Eur Heart J · 2023-01-01

研究纳入15国36个中心419例临床疑似暴发性心肌炎成人患者,比较入住ICU后2天内早期心内膜心肌活检与延迟活检的1年无心脏移植或左室辅助装置生存。

要点

  • 暴发性心肌炎疑似患者应尽早行心内膜心肌活检,不应延迟。
  • 早期活检组1年无移植/左室辅助装置生存率高于延迟活检组。
  • 早期活检与1年死亡或移植/左室辅助装置风险降低独立相关。

核心结论

  • 对ICU收治的临床疑似暴发性心肌炎成人患者,心内膜心肌活检应广泛且及时使用。

研究设计与样本

  • 多中心回顾性研究,纳入15国36个三级中心419例临床疑似暴发性心肌炎成人患者。
  • 210例(50%)经组织学确诊心肌炎,其中心内膜心肌活检183例(44%),尸检或移植心脏检查27例(6%)。
  • 96例(23%)经心脏磁共振临床疑似确诊。
  • 比较入住ICU后2天内早期活检(n=103)与延迟活检(n=80)的1年无心脏移植或左室辅助装置生存,采用倾向评分加权控制混杂。

主要发现

  • 入组中位年龄40(29-52)岁,322例(77%)接受临时机械循环支持。
  • 273例(65%)存活且未行心脏移植或左室辅助装置。

临床怎么用

  • 对ICU临床疑似暴发性心肌炎成人患者,应尽早(入住ICU后2天内)行心内膜心肌活检以明确诊断并指导治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: While endomyocardial biopsy (EMB) is recommended in adult patients with fulminant myocarditis, the clinical impact of its timing is still unclear. METHODS: Data were collected from 419 adult patients with clinically suspected fulminant myocarditis admitted to intensive care units across 36 tertiary centres in 15 countries worldwide. The diagnosis of myocarditis was histologically proven in 210 (50%) patients, either by EMB (n = 183, 44%) or by autopsy/explanted heart examination (n = 27, 6%), and clinically suspected cardiac magnetic resonance imaging confirmed in 96 (23%) patients. The primary outcome of survival free of heart transplantation (HTx) or left ventricular assist device (LVAD) at 1 year was specifically compared between patients with early EMB (within 2 days after intensive care unit admission, n = 103) and delayed EMB (n = 80). A propensity score-weighted analysis was done to control for confounders. RESULTS: Median age on admission was 40 (29-52) years, and 322 (77%) patients received temporary mechanical circulatory support. A total of 273 (65%) patients survived without HTx/LVAD. The primary outcome was significantly different between patients with early and delayed EMB (70% vs. 49%, P = .004). After propensity score weighting, the early EMB group still significantly differed from the delayed EMB group in terms of survival free of HTx/LVAD (63% vs. 40%, P = .021). Moreover, early EMB was independently associated with a lower rate of death or HTx/LVAD at 1 year (odds ratio of 0.44; 95% confidence interval: 0.22-0.86; P = .016). CONCLUSIONS: Endomyocardial biopsy should be broadly and promptly used in patients admitted to the intensive care unit for clinically suspected fulminant myocarditis.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Huang F, Ammirati E, Ponnaiah M, et al. Fulminant myocarditis proven by early biopsy and outcomes. Eur Heart J. 2023. PMID: 37941449. doi:10.1093/eurheartj/ehad707

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。